Taxifolin Market: Global Industry Analysis and Forecast (2023-2029)

Taxifolin Market size was valued at US$ 511.56 Mn. in 2022 and the total Taxifolin revenue is expected to grow at 4.4% from 2023 to 2029, reaching nearly US$ 691.51 Mn.

Taxifolin Market Overview:

Taxifolin i.e. TXF, commonly known as dihydroquercetin, is a popular flavanonol with strong antioxidant effects. TXF's antioxidant and antiradical activities have been proven using several in vitro bioanalytical antioxidant methodologies. TXF has been shown in studies to be an anti-inflammatory, hypopigmented, and anticancer agent, as well as to reduce oxidative DNA damage and minimize Ultraviolet-induced skin malignancy. TXF is non-toxic, protects the body from photoaging, and prevents cellular proliferation. To match customer expectations, the cosmetics sector looks for effective products from natural sources. From this vantage point, the utilization of TXF as a lead component in the development of novel organic beauty products for adults is enticing. In this report, the Taxifolin market's growth reasons, as well as the market's many segments (Purity Level, Type, Application, and Region), are discussed. Data has been given by market players, regions, and specific requirements. This market report includes a comprehensive overview of all the significant improvements that are presently prevailing in all market segments. Key data analysis is presented in the form of statistics, infographics, and presentations. The study discusses the Taxifolin market's Drivers, Restraints, Opportunities, and Challenges. The report helps to assess the market growth drivers and determines how to use these drivers as a tool. The report also helps to rectify and resolve issues related to the global Taxifolin market situation.Global Taxifolin MarketTo know about the Research Methodology :- Request Free Sample Report

Taxifolin Market Dynamics:

The rising cases of skin cancer all over the world are a major driver of the market growth. Skin cancer is classified into two categories: melanoma and non-melanoma. Basal cell carcinoma and squamous cell carcinoma are the most frequent non-melanoma cancers. Melanoma of the skin is the 18th most prevalent malignancy in both men and women. In 2018, there were about 295,000 new cases. Non-melanoma skin cancer is the fifth most frequent malignancy in men and women, with over 1.01 million cases in 2018, albeit this figure is likely to be underestimated. Besides that, many cancer cases are not detected or recorded: certain nations do not have cancer databases, parts of some countries have few or no records, documents in countries experiencing conflict or other disruption are sure to be inadequate, and some cancer patients do not seek medical attention. Because of these variables, the reported worldwide incidence of skin cancer is likely to be understated. Non-melanoma skin cancer is also frequently overlooked in comparisons of the most prevalent malignancies. The key opportunity in the market is that consumers in emerging nations are changing their lifestyles and purchasing power is rising. The rising urbanization, an increase in the number of working women, demographic shifts, and more knowledge about cleanliness and skincare are expected to create favorable growth prospects for the market. The increased awareness of personal cleanliness and health has increased the need for cosmeceuticals. This shift has resulted in increasing production of dermatology and hair care products, fuelling demand for personal care chemicals. Most emerging nations, particularly China, Brazil, and Argentina, are witnessing a significant shift in consumer habits. Increased income and buying power support the growth. These factors have raised the demand in these nations for homecare chemicals. The general public's knowledge of cleanliness, attractiveness, and health has been constantly rising. The higher costs associated with enhanced and organic cosmetic products are a major restraint in the market growth. The hazards of using conventional synthetic beauty products have been brought to the forefront by natural products. To reduce the issues produced by harmful chemical makeup on the body, there is a drive toward the use of organic replacements. Organic components in cosmetic formulae, for example, are gaining popularity as a potential substitute. Manufacturers are focusing on items that are both safe for fitness and smooth and relaxing on the skin. The main obstacle, however, is pricing, as organic cosmetics have higher raw material prices and can only match the demand for premium product lines. As a result, businesses find it difficult to dedicate appropriate financing for research activities.

Taxifolin Market Segment Analysis:

By Type, the pharmaceutical grade segment is expected to grow at a CAGR of 4.2% in the forecast period. Flavonoids are polyphenolic chemicals found in high concentrations in most fruit and veggies. They have piqued the interest of researchers for many years due to their physiological and pharmaceutical properties, which may assist in the treatment of a wide range of human ailments. Taxifolin, also known as dihydroquercetin, is a flavonoid present in fresh fruits, leafy vegetables, chocolate, and tea. Recent studies have revealed that taxifolin's therapeutic properties may aid in the treatment of disorders in which swelling, apoptosis, and oxidative stress play a fundamental role. Global Taxifolin MarketTaxifolin has also been shown to engage with cellular functions, resulting in cell cycle inhibition, which may lead to tumor growth reversal. Taxifolin has been shown to reach significant amounts in kidney tissues to protect renal cells from oxidative damage. Moreover, taxifolin has been shown to suppress p-glycoprotein production, which is accountable for the renal absorption of several nephrotoxic drugs.

Taxifolin Market Regional Insights:

APAC market is expected to grow at the fastest rate of 3.3% during the forecast period, owing to increased expenditures by the governments of different nations in the area and the private industry in the research & development of medications with few or no adverse effects. Other drivers anticipated to fuel revenue growth in the APAC taxifolin market include government efforts to improve local manufacture of low-cost, high-quality medicines that can significantly cut imports, particularly in China. Additionally, rising demand for taxifolin in main applications e. g. medicine and food, as well as increased acceptance of athletic nourishment as a consequence of more domestic and international sporting events, are likely to drive market growth in the area. Besides that, soaring inclination towards nutrients among inhabitants due to increased awareness about the benefits of consuming multivitamins, as well as spreading awareness about the health advantages of taxifolin e.g. vitamins, and important medicinal derivatives, are the driving factors in the regional market growth. The objective of the report is to present a comprehensive analysis of the Taxifolin market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Taxifolin market dynamics, and structure by analyzing the market segments and projecting the Taxifolin market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Taxifolin market make the report investor’s guide.

Taxifolin Market Scope: Inquiry Before Buying

Global Taxifolin Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2017 to 2022 Market Size in 2022: US $ 511.56 Mn.
Forecast Period 2023 to 2029 CAGR: 4.4 % Market Size in 2029: US $ 691.51 Mn.
Segments Covered: by Purity Level • <95% • >95%
by Type • Industrial Grade • Pharmaceutical Grade • Food Grade
by Application • Food & Beverages • Pharmaceuticals • Healthcare • Agriculture • Cosmetics • Others

Taxifolin Market, by Region

● North America (United States, Canada and Mexico) ● Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe) ● Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC) ● Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) ● South America (Brazil, Argentina, Columbia and Rest of South America).

Taxifolin Market, Key Players are:

JW Health Products • Kingherbs Ltd • Cayman Chemical • Ametis JSC • Abcam plc • Adooq Bioscience • ROBIOS • Creative Enzymes • Sigma-Aldrich • BOC Sciences • Linjiang Jianwei Biotech Co.Ltd • Hangzhou J&H Chemical Co.Ltd. • Career Henan Chemical • Hefei TNJ Chemical Industry • A2B Chem LLC FAQs: 1. Which is the potential market for the Taxifolin in terms of the region? Ans. The APAC market is expected to grow at the fastest rate of 3.3% during the forecast period. 2. What are the opportunities for new market entrants? Ans. The key opportunity in the market is that consumers in emerging nations are changing their lifestyles and purchasing power is rising. 3. What is expected to drive the growth of the Taxifolin market in the forecast period? Ans. The rising cases of skin cancer all over the world are a major driver of the market growth. 4. What is the projected market size & growth rate of the Taxifolin Market? Ans. Taxifolin Market size was valued at US$ 511.56 Mn. in 2022 and the total Taxifolin revenue is expected to grow at 4.4% from 2023 to 2029, reaching nearly US$ 691.51 Mn. 5. What segments are covered in the Taxifolin Market report? Ans. The segments covered are Purity Level, Type, Application, and Region.
1. Global Taxifolin Market: Research Methodology 2. Global Taxifolin Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Taxifolin Market 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Taxifolin Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • South America 3.12 COVID-19 Impact 4. Global Taxifolin Market Segmentation 4.1 Global Taxifolin Market, by Application (2023-2029) • Food & Beverages • Pharmaceuticals • Healthcare • Agriculture • Cosmetics • Others 4.2 Global Taxifolin Market, by Type (2023-2029) • Industrial Grade • Pharmaceutical Grade • Food Grade 4.3 Global Taxifolin Market, by Purity Level (2023-2029) • <95% • >95% 5. North America Taxifolin Market(2023-2029) 5.1 North America Taxifolin Market, by Application (2023-2029) • Food & Beverages • Pharmaceuticals • Healthcare • Agriculture • Cosmetics • Others 5.2 North America Taxifolin Market, by Type (2023-2029) • Industrial Grade • Pharmaceutical Grade • Food Grade 5.3 North America Taxifolin Market, by Purity Level (2023-2029) • <95% • >95% 5.4 North America Taxifolin Market, by Country (2023-2029) • United States • Canada • Mexico 6. Europe Taxifolin Market (2023-2029) 6.1. European Taxifolin Market, by Application (2023-2029) 6.2. European Taxifolin Market, by Type (2023-2029) 6.3. European Taxifolin Market, by Purity Level (2023-2029) 6.4. European Taxifolin Market, by Country (2023-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Taxifolin Market (2023-2029) 7.1. Asia Pacific Taxifolin Market, by Application (2023-2029) 7.2. Asia Pacific Taxifolin Market, by Type (2023-2029) 7.3. Asia Pacific Taxifolin Market, by Purity Level (2023-2029) 7.4. Asia Pacific Taxifolin Market, by Country (2023-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. Middle East and Africa Taxifolin Market (2023-2029) 8.1 Middle East and Africa Taxifolin Market, by Application (2023-2029) 8.2. Middle East and Africa Taxifolin Market, by Type (2023-2029) 8.3. Middle East and Africa Taxifolin Market, by Purity Level (2023-2029) 8.4. Middle East and Africa Taxifolin Market, by Country (2023-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Taxifolin Market (2023-2029) 9.1. South America Taxifolin Market, by Application (2023-2029) 9.2. South America Taxifolin Market, by Type (2023-2029) 9.3. South America Taxifolin Market, by Purity Level (2023-2029) 9.4 South America Taxifolin Market, by Country (2023-2029) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1 JW Health Products 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2 Kingherbs Ltd 10.3 Cayman Chemical 10.4 Ametis JSC 10.5 Abcam plc 10.6 Adooq Bioscience 10.7 ROBIOS 10.8 Creative Enzymes 10.9 Sigma-Aldrich 10.10 BOC Sciences 10.11 Linjiang Jianwei Biotech Co.Ltd 10.12 Hangzhou J&H Chemical Co.Ltd. 10.13 Career Henan Chemical 10.14 Hefei TNJ Chemical Industry 10.15 A2B Chem LLC
  • INQUIRE BEFORE BUYING